Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Change in Receivables (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Change in Receivables for 16 consecutive years, with $101398.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 87.06% to $101398.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $405881.0, a 79.7% decrease, with the full-year FY2025 number at $405881.0, down 79.7% from a year prior.
  • Change in Receivables was $101398.0 for Q4 2025 at Cryo Cell International, down from $315517.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $992481.0 in Q4 2022 to a low of -$593114.0 in Q1 2021.
  • A 5-year average of $258096.4 and a median of $345755.5 in 2024 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: plummeted 233.86% in 2021, then soared 1330.11% in 2022.
  • Cryo Cell International's Change in Receivables stood at $69399.0 in 2021, then skyrocketed by 1330.11% to $992481.0 in 2022, then crashed by 53.86% to $457934.0 in 2023, then surged by 71.18% to $783870.0 in 2024, then crashed by 87.06% to $101398.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Change in Receivables are $101398.0 (Q4 2025), $315517.0 (Q3 2025), and -$185132.0 (Q2 2025).